Results

Total Results: 491 records

Showing results for "pulmonary".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
    October 22, 2012 - Such chronic cough is responsible for up to 38 percent of pulmonary outpatient visits.2,3 Although … This review, mainly in patients with asthma and chronic obstructive pulmonary disease, found that cough … Underlying etiologies (asthma, GERD, upper airway cough syndrome, tobacco use, ACE inhibitor use, pulmonary … Underlying etiologies • Asthma • GERD • Upper airway cough syndrome • Tobacco use • ACE inhibitor user • Pulmonary … Underlying etiologies (asthma, GERD, upper airway cough syndrome, tobacco use, ACE inhibitor use, pulmonary
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - use may also explain its limited use in conditions other than in patients with chronic obstructive pulmonary … disease (COPD) and acute cardiogenic pulmonary edema (ACPE). … comparing CPAP and BPAP have been addressed repeatedly in previous literature (mainly for cardiogenic pulmonary … Peer Reviewer 4 Methods 5) I don't think the various potential indications for NIV (COPD, pulmonary … COPD, pulmonary edema, etc) either in a trial-level meta-regression or a stratified analysis?
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
    January 01, 2012 - patient data systematic review of inhaled budesonide among participants with chronic obstructive pulmonary … One example is exercise therapy 32 for patients with chronic obstructive pulmonary disease. … For example, phosphodiesterase-4 inhibitors are new drugs for patients with chronic obstructive pulmonaryPulmonary rehabilitation for chronic obstructive pulmonary disease. … Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
  4. effectivehealthcare-admin.ahrq.gov/products/congestive-heart-failure-medicines/research
    January 01, 2020 - Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias … by H-ISDN exposure: COMORBIDITY (Quan 13 modification of Elixhauser 30 ): Valvular heart disease, Pulmonary … circulation disorders, Paralysis, Other neurologic disorders, Chronic pulmonary disease, Liver disease
  5. effectivehealthcare-admin.ahrq.gov/products/hypertensive-disorders-pregnancy/protocol
    April 01, 2022 - mm Hg or higher 17 ), low platelet count, abnormal liver function, acute abnormal kidney function, pulmonary … between MgSO4 and specific antihypertensive agents, such as hypotension, neuromuscular blockade, or pulmonary … including pregnancy-related mortality* Severe maternal morbidity* (e.g., stroke* , eclampsia, pulmonary … including pregnancy-related mortality* Severe maternal morbidity* (e.g., stroke*, eclampsia, pulmonary
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
    April 20, 2022 - mm Hg or higher17), low platelet count, abnormal liver function, acute abnormal kidney function, pulmonary … between MgSO4 and specific antihypertensive agents, such as hypotension, neuromuscular blockade, or pulmonary … mortality, including pregnancy-related mortality* o Severe maternal morbidity* (e.g., stroke*, eclampsia, pulmonary … mortality, including pregnancy-related mortality* o Severe maternal morbidity* (e.g., stroke*, eclampsia, pulmonary
  7. effectivehealthcare-admin.ahrq.gov/products/mental-health-pregnancy/research
    March 01, 2022 - and spontaneous abortion, and child outcomes such as respiratory issues, low Apgar scores, persistent pulmonary
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - (75)* IC: 9* (56.3)* SOT Diabetes: 11 (39.3) Arterial hypertension: 19 (67.9) Obesity: 6 (21.4) Pulmonary … 7.1) Heart disease: 6 (21.4) IC Diabetes: 1 (6.3) Arterial hypertension: 6 (37.5) Obesity: 3 (18.8) Pulmonary … Cancer pt: 62 (21) NR Total: 48 (28.9) HCW: 29 (27.6) Cancer pt: 19 (31.1) Total Cardiovascular: 5 (3) Pulmonary … 5.4) Diabetes: 6 (3.6) Autoimmunity: 15 (9) Hypertension: 19 (11.4) HCW: Cardiovascular: 3 (2.9) Pulmonary … 6.7) Diabetes: 1 (1) Autoimmunity: 13 (12.4) Hypertension: 3 (2.9) Cancer: Cardiovascular: 2 (3.3) Pulmonary
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
    September 01, 2011 - The pulmonary edema comments (Results, page 68-69) are concerning as it is said those studies were likely … underpowered when there were over 1200 cases and the incidence of pulmonary edema was certainly less … The two studies by Lam et al, under Pulmonary oedema, were judged as underpowered not because of the
  10. MEDLINE Searches (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - Spontaneous reports of pulmonary embolism in association with raloxifene. … Pulmonary embolism, deep vein thrombosis, composite measures of coronary heart disease, myocardial … Composite thromboembolic events, pulmonary embolism, deep venous thrombosis, cardiovascular outcomes … Deep venous thrombosis, pulmonary embolism, concussion, headache, vertigo, abdominal pain, vaginal … Deep venous thrombosis, pulmonary embolism, vaginal bleeding, moniliasis, allergy, anxiety, nervousness
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/preoperative-testing_research-protocol.pdf
    May 14, 2013 - radiography   o 12-­‐lead  ECG   o Cardiac  stress  testing   o Basic  echocardiography   o Pulmonary … specific  surgical  planning  (e.g.,  imaging  tests  for  extent  of   cancer,  pulmonary … We will not be evaluating whether preoperative test results (e.g., abnormal vs. normal pulmonary function
  12. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - However, several experts noted that patients will need to be screened for pulmonary conditions to be … This allows insulin to be absorbed into pulmonary arterial circulation, to achieve rapid systemic delivery … Afrezza therapy was associated with reduced pulmonary function that occurred during the first 3 months … Thus, candidates should undergo pulmonary testing (spirometry [FEV1]) to screen for respiratory conditions … clinical expert stated, “Observational data suggest potential side effects, such as a decrease in pulmonary
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
    January 01, 2015 - Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. … Tiotropium versus placebo for chronic obstructive pulmonary disease. … Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. … Integrated disease management interventions for patients with chronic obstructive pulmonary disease … Pulmonary artery catheters for adult patients in intensive care.
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
    December 01, 2023 - (including prepregnancy body mass index, diabetes, hypertension, cardiac disease, renal disease, pulmonary
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
    February 01, 2021 - life-threatening chronic illness or conditions (e.g., advanced heart failure, chronic obstructive pulmonary
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
    April 01, 2021 - between selective serotonin reuptake inhibitors and respiratory issues, low Apgar scores, persistent pulmonary
  17. effectivehealthcare-admin.ahrq.gov/products/preoperative-testing/research-protocol
    December 01, 2019 - Pregnancy tests Chest radiography 12-lead ECG Cardiac stress testing Basic echocardiography Pulmonary … surgery is being performed or for specific surgical planning (e.g., imaging tests for extent of cancer, pulmonary … We will not be evaluating whether preoperative test results (e.g., abnormal vs. normal pulmonary function
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias … variables by H-ISDN exposure: COMORBIDITY (Quan 13 modification of Elixhauser 30): Valvular heart disease, Pulmonary … circulation disorders, Paralysis, Other neurologic disorders, Chronic pulmonary disease, Liver disease
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
    July 01, 2010 - Clinical Modification [ICD-9-CM] codes 140-172, 174-195, 200-208, and 238.6), chronic obstructive pulmonary … — 9808 (14.7) 1280 (17.4) Cerebrovascular disease — 31 822 (47.7) 4462 (60.6) Chronic obstructive pulmonary … 0.94 (0.90-0.98)c Cerebrovascular disease 0.49 (0.48-0.49)b 0.68 (0.65-0.70)b Chronic obstructive pulmonary
  20. effectivehealthcare-admin.ahrq.gov/products/chronic-cough/research-protocol
    December 01, 2020 - Such chronic cough is responsible for up to 38 percent of pulmonary outpatient visits. 2 , 3 Although … This review, mainly of patients with asthma and chronic obstructive pulmonary disease, found that cough … GERD, upper airway cough syndrome, tobacco use, use of an angiotensin-converting enzyme inhibitor, pulmonary … Underlying etiologies (asthma, GERD, upper airway cough syndrome, tobacco use, ACE inhibitor use, pulmonary

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: